The India-based biotech company acquired the plant near Johns Hopkins Bayview Hospital in April for $36.5 million.

Syngene International, a global research company, announced it will be establishing its first U.S. facility in Baltimore.

The future will be divided between those who possess knowledge and those who do not have it, Krishna M. Ella, founder and Executive Chairman of Bharat Biotech International Ltd, has said.

The price band for the initial public offering (IPO) of Gem Aromatics, which is set to open next week, has been fixed at ₹309 ...

The FTA will provide Indian exporters with more price competitiveness, faster customs clearance, and greater market certainty ...

US President Donald Trump has labelled India as the "Tariff King" and an "abuser" of trade duties, suggesting the country ...

Unauthorised herbicide-tolerant cotton varieties circulate in Dhar district of Madhya Pradesh: Ambika Subash* reports ...

After Donald Trump escalated the tariff clash by bringing Russian oil into the picture, India is looking to leverage its key ...

The global Health Care industry has steeply underperformed regional equity indices over the last two years and notably since ...

Read the Latest Union Budget 2025 News on The Economic Times. Discover Latest Budget Updates, India Budget Expectations, ...

Gujarat's startup scene is experiencing a funding revival, attracting nearly ₹400 crore since April. RENÉE Cosmetics led with ...

The new processing facility in Malaysia will increase production capacity for seaweed-based functional ingredients for ...